PALO ALTO, Calif., March 17, 2016 – Centrillion Technologies, a leading genomic technology company developing and commercializing transformative genomic analysis tools, has named Dr. Tzu Kun (TK) Ku as its Vice President of Technology Research and Operations for its subsidiary in Hsinchu Taiwan, R.O.C. Dr. Ku joins Centrillion from Taiwan’s Industry Technology Research Institute (ITRI)’s Nano-electronic Technology Division, where he served as a Division Director.
Headquartered in Palo Alto, California, Centrillion is developing and commercializing genomic technologies that dramatically improve accuracy, reduce cost, and improve efficiency of genomics research and diagnostics. Centrillion’s products will be used by customers working in life sciences, molecular diagnostics, reproductive health, agricultural biotechnology and consumer genomics.
“We are excited to have Dr. Ku join us,” noted Dr. James Zhang, Chief Strategy Officer of Centrillion Technologies, who is spearheading its Taiwan operations. “With its very large population base and its increasing affluence, the genomics market in Asia is expected to be very large and grow rapidly. TK’s experience in advanced manufacturing and knowledge in process development is exactly what we need.”
“I am thrilled to be part of such an exciting mission, where I can use my knowledge of precision manufacturing and process development to help the company achieve its lofty goals,” added Dr. Ku. “I look forward to the exciting task of helping the company transform from a great R&D organization into a successful commercial enterprise.”
Before joining ITRI as the Director of its Nano-electronic Technology Division, Dr. Ku was a director at XGI Technology Inc. Dr. Ku holds an EMBA from the National Taiwan University, a Ph.D. of Electronic Engineering from the National Chao-Tung University (Taiwan) and Master of Electronic Physics from National Chao-Tung University (Taiwan). He holds over 30 patents and 15 publications in international journals plus over 50 international conference papers.
About Centrillion Technologies
Centrillion Technologies is enabling scientists to decode and analyze the full genome and helping them power breakthroughs across a multitude of previously unapproachable applications in human health, agriculture and environmental studies. Leveraging the latest advances in engineering and biochemistry, the company’s products and services can isolate, manipulate, visualize, and analyze intact kilobase and megabase fragments of DNA, all with an accurate, simple and affordable workflow. Founded in 2009, Centrillion is led by former Affymetrix executives, backed by leading venture capital and strategic investors and is headquartered in the center of innovation of Silicon Valley in Palo Alto, Calif. near Stanford University. For more information, please visit: www.CentrillionTech.com.
Sard Verbinnen & Co
Megan Bouchier/David Isaacs